Nomura Holdings, Inc.
NYSE:NMRFinancial - Capital Markets
-$0.12 today
- Market cap
- $27.29B
- Beta
- 0.61
- P/E (TTM)
- 0.3
- EPS (TTM)
- $4,986.67
- Dividend yield
- 3.55%
Volume 3.51M
Average 1.75M
NMR Stock-Based Compensation
Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.
Nomura Holdings, Inc.NYSE: NMR
Stock-Based Compensation · Q4 FY2026 · quarter ended Mar 2026
Stock-based compensation grows in line with its trailing trend
Q4 FY2026 stock-based compensation of ¥56.42B rose 21.1% year over year, in line with the +21.1% change in trailing-twelve-month stock-based compensation.
Context
- Stock-based compensation amounted to 0.0% of revenue in FY2026, down 0.9 pp from a year earlier.
- Stock-based compensation increased in 1 of the last 3 fiscal years.
- FY2026 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +21.1% holds above the trailing-twelve-month pace of +21.1%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Stock-Based Compensation history
JPY · from the cash flow
- Latest · FY2026
- 0 JPY
- Year-over-year change
- -100.0%
| Period | Period end | Stock-Based Compensation | YoY change |
|---|---|---|---|
| FY2026 | 2026-03-31 | 0 | -100.0% |
| FY2025 | 2025-03-31 | 38.58B | -25.1% |
| FY2024 | 2024-03-31 | 51.51B | +46.3% |
| FY2023 | 2023-03-31 | 35.22B | +26.0% |
| FY2022 | 2022-03-31 | 27.94B | — |
Stock-Based Compensation vs competitors
How NMR compares with its peers on the latest reported figures
- Peers report in different currencies, so stock-based compensation is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +21.1% is the 4th highest of 8, against a peer median of +13.4%.
- Stock-based compensation amounts to 1.2% of revenue for NMR, versus a peer median of 2.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | ¥56.42B JPY | +21.1% | — | 1.2% | |
| LTM Jun 2026 | $3.46B USD | +9.1% | -5.5% | 2.9% | |
| LTM Sep 2026 | $1.6B USD | -13.3% | +0.9% | 1.2% | |
| LTM Jun 2026 | $937.52M USD | +53.5% | +13.0% | 19.8% | |
| LTM Jun 2026 | $444.62M USD | +174.4% | +6.6% | 6.7% | |
| LTM Sep 2026 | $407.16M USD | +13.4% | — | 12.1% | |
| LTM Aug 2026 | $116.18M USD | +40.0% | +26.2% | 0.9% | |
| LTM Mar 2026 | $31.49M USD | -29.2% | +26.5% | 1.8% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding NMR) | — | +13.4% | +9.8% | 2.4% | |
Competitors are the stored peer set for NMR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2022 Mar 2022 | FY2023 Mar 2023 | FY2024 Mar 2024 | FY2025 Mar 2025 | FY2026 Mar 2026 |
|---|---|---|---|---|---|
| Net Income | 146.53B | 91.68B | 177.22B | 347.26B | 374.38B |
| Depreciation & Amortization | 59.52B | 61.42B | 61.34B | 61.65B | 68.27B |
| Deferred Income Tax | 3.11B | 6.14B | (312M) | 11.56B | 0 |
| Stock-Based Compensation | 27.94B | 35.22B | 51.51B | 38.58B | 0 |
| Change in Working Capital | (874.99B) | (453.66B) | (116.12B) | (1.11T) | (1.23T) |
| Accounts Receivables | 0 | 0 | 0 | 0 | (653.33B) |
| Inventory | 0 | 0 | 0 | 0 | (2.86T) |
| Accounts Payables | (247.98B) | (139.42B) | 709.84B | 0 | 1.81T |
| Other Working Capital | (627.01B) | (314.25B) | (825.95B) | (1.11T) | 474.21B |
| Other Non-Cash Items | (224.95B) | (435.61B) | (41.01B) | (25.47B) | (59.57B) |
| Operating Cash Flow | (862.83B) | (694.82B) | 132.64B | (678.61B) | (842.96B) |
| Capital Expenditures | (111.33B) | (171.17B) | (145.78B) | (189.97B) | (353.82B) |
| Acquisitions (Net) | 0 | 16.95B | (457M) | 8.14B | (275B) |
| Purchases of Investments | (115.21B) | (75.5B) | (156.93B) | (322.45B) | (8.9T) |
| Sales of Investments | 205.53B | 301.07B | 177.09B | 154.39B | 7.95T |
| Other Investing Activities | (572.17B) | (304.58B) | (761.85B) | (498.76B) | (151.66B) |
| Investing Cash Flow | (593.18B) | (233.23B) | (887.94B) | (848.65B) | (1.5T) |
| Debt Repayment | 861.78B | 1.02T | 1.03T | 1.1T | 1.55T |
| Common Stock Issued | 11M | 4M | 953M | 1.41B | 422M |
| Common Stock Repurchased | (39.65B) | (24.73B) | (61.03B) | (59.01B) | (101.5B) |
| Dividends Paid | (70.71B) | (57.26B) | (60.16B) | (112.54B) | (179.74B) |
| Other Financing Activities | 361.29B | 341.9B | 116.79B | 748.75B | 828.23B |
| Financing Cash Flow | 1.11T | 1.28T | 1.01T | 1.68T | 2.1T |
| Effect of Forex Changes | 149.69B | 148.55B | 220.62B | (26.02B) | 139.31B |
| Net Change in Cash | (193.6B) | 504.44B | 478.17B | 126.42B | (106.72B) |
| Free Cash Flow | (974.16B) | (865.99B) | (13.14B) | (868.58B) | (1.2T) |
Nomura Holdings, Inc.
NYSE:NMR
Intrinsic Alpha fair value
Locked
Current Price
$9.23
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.